Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.
He LN, Chen T, Fu S, Jiang Y, Zhang X, Chen C, Du W, Luo L, Li A, Wang Y, Yu H, Zhou Y, Wang Y, Yang Y, Huang Y, Zhao H, Fang W, Zhang L, Hong S.
He LN, et al. Among authors: chen c, chen t.
Ther Adv Med Oncol. 2023 Oct 24;15:17588359231200463. doi: 10.1177/17588359231200463. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37881238
Free PMC article.